However, inflammatory monocytes recruited by CCL2 can also differentiate into monocyte-derived dendritic cells, which can present antigens to CD8 + and CD4 + T cells, thus assisting and stimulating the adaptive anti-tumor immune response. This evidence concerns the gene CD4 and neoplasm.